Human Fertility, published by Taylor & Francis Ltd, is a key academic journal that serves the dynamic fields of medicine, obstetrics and gynecology, and reproductive medicine. Established in 1998 and with converged content extending to 2024, the journal holds a notable Q2 ranking in its respective categories, highlighting its influence and scholarly contributions to current research and practice. With an ISSN of 1464-7273 and an E-ISSN of 1742-8149, it rigorously disseminates studies, reviews, and advancements in human fertility, particularly emphasizing evidence-based practices and innovative techniques. Despite its traditional subscription model, the journal remains vital for researchers, healthcare professionals, and students seeking to foster advancements in reproductive health. Its articles are pivotal in addressing the multifaceted challenges faced in reproductive health and guiding future research trajectories.

Basic and Clinical Andrology, published by BMC, is a leading open access journal dedicated to the advancement of knowledge in the field of reproductive medicine and urology. Since its launch in 2013, the journal has aimed to provide a platform for the dissemination of high-quality research, bridging the gap between basic science and clinical practice. With an impressive reputation evidenced by its Q2 ranking in both reproductive medicine and urology, it serves as a vital resource for researchers, healthcare professionals, and students looking to stay updated on the latest developments in andrology. The journal actively encourages submissions across a diverse range of topics, contributing to our understanding of male reproductive health issues, advancements in treatment protocols, and innovative therapeutic approaches. Located in the United Kingdom, Basic and Clinical Andrology plays a critical role in the global discourse on andrology, offering researchers an opportunity to share their findings with a broad audience committed to improving health outcomes in these crucial fields.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

ASIAN JOURNAL OF ANDROLOGY, published by Wolters Kluwer Medknow Publications, is a leading Open Access journal in the fields of urology and andrology. Since its inception in 1999, this journal has been instrumental in disseminating pivotal research that advances understanding and promotes progress within these specialty areas. With an impressive impact factor and a Scopus ranking of #27 out of 120 in Medicine (Urology), it is recognized for its contributions to both academia and clinical practice. The journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and developments in male reproductive health and related fields, making it a key resource for anyone striving to enhance their knowledge and expertise. Based in India, the ASIAN JOURNAL OF ANDROLOGY is committed to fostering global discussions and collaborations that bind the scientific community together in the quest for innovation and improved patient outcomes.

PROSTATE is a premier, peer-reviewed journal published by Wiley, focusing on the critical fields of urology and oncology. With an established history since 1980 and a projected convergence through 2024, this influential journal serves as a vital resource for researchers, clinicians, and students alike. It holds a prestigious position in the academic landscape, classified in the Q1 category for Urology and Q2 in Oncology as of 2023, demonstrating its significant contribution to these disciplines. With a Scopus rank of #23 in Urology and #169 in Oncology, PROSTATE is pivotal for advancing knowledge and fostering innovation in prostate research, treatment, and overall male health. The journal aims to publish high-quality original articles, reviews, and clinical studies that address the complexities of prostate-related conditions, ultimately seeking to improve patient outcomes and propagate best practices in the medical community.

Revista Internacional de Andrologia, published by Elsevier España SLU, is a pivotal academic journal advancing the field of andrology, particularly focusing on reproductive medicine and urology. With an ISSN of 1698-031X and recognized as a reputable source within the medical community, this journal holds a Q3 ranking in both Reproductive Medicine and Urology as of 2023, reflecting its significant contribution to the field. Researchers and professionals are encouraged to engage with a diverse range of articles published annually, offering insights into current trends, innovative methodologies, and emerging challenges. Although the journal is not open access, it is an essential resource for those seeking to stay at the forefront of research and practice in andrology, making it a valuable tool for academics and clinicians alike. As the journal progresses through its converged years from 2005 to 2024, it remains committed to fostering collaboration and knowledge dissemination within the global medical community.

The Journal of Urology stands as a premier publication in the field of urology, dedicated to advancing the understanding and treatment of urological diseases. Published by Lippincott Williams & Wilkins, this esteemed journal has maintained a strong presence since its inception in 1945, converging research and clinical practice until 2024. With an impressive impact factor that underscores its relevance and influence in the field—ranking 4th out of 120 in Urology according to Scopus—this journal is a vital resource for clinicians, researchers, and students alike. As a Q1 journal in its category for 2023, it boasts a high degree of visibility and rigorous peer-review standards, making it an essential reading for those wishing to stay abreast of the latest discoveries and technological advancements in urological health. Although it does not offer open access, the journal's commitment to disseminating high-quality research ensures its continued impact on both the academic community and clinical practice.

ANDROLOGIA is a distinguished journal published by Wiley, focusing on the vital fields of andrology, urology, and endocrinology. Since its inception in 1969, this journal has become a key resource for researchers, clinicians, and students, striving to advance the understanding of male reproductive health and related disorders. With an impressive impact factor and recognition in category quartiles such as Q2 in both Medicine (miscellaneous) and Urology for 2023, ANDROLOGIA has established itself as a leading platform, ranking 16th out of 120 in Urology. Though not an open-access journal, it offers valuable insights through a rigorous peer-review process and a commitment to disseminating high-quality research. The journal's scope is broad, encompassing all aspects of andrology and its implications within medicine, ensuring it remains relevant to the evolving landscape of health sciences. Researchers looking to publish their work or keep abreast of recent discoveries will find ANDROLOGIA an essential addition to their academic resources.

PROSTATE CANCER AND PROSTATIC DISEASES, published by SpringerNature, is a prestigious international journal dedicated to advancing knowledge in the fields of cancer research, oncology, and urology, as evidenced by its Q1 rankings in 2023. Established in 1997, this journal has become a vital resource for researchers, clinicians, and healthcare professionals, offering impactful research and clinical insights on prostate health and disease. With its focus on innovative studies and comprehensive reviews, it addresses critical challenges in the management and treatment of prostate cancer, driving improvements in patient care globally. The journal's standing is further supported by its impressive Scopus rankings, placing it in the top tier of its categories. Readers can access high-quality, peer-reviewed articles that contribute significantly to ongoing medical practices and improve therapeutic strategies for prostate-related health issues.

Prostate International is a leading open-access journal published by Elsevier Inc, dedicated to advancing research and knowledge in the field of urology, particularly focusing on prostate health and disease. Since its inception in 2013, the journal has preserved its commitment to disseminating high-quality, peer-reviewed articles that contribute significantly to clinical practices and scientific understanding. With an impressive Q1 ranking in urology and a current position as rank #35/120 among urology journals in Scopus, it occupies a prominent place in the academic landscape, ensuring that cutting-edge research reaches a broad audience. The journal's open-access policy enhances visibility and accessibility, fostering collaboration among researchers, healthcare professionals, and students. With the range of topics covered, from innovative treatments to diagnostic advancements, Prostate International serves as a vital resource for those committed to improving patient outcomes and driving the future of urological health.